Patents Assigned to BENCHMARK ANIMAL HEALTH LIMITED
  • Patent number: 10653763
    Abstract: The present disclosure provides an immersion vaccine for fish comprising at least one isolated antigen, specifically a recombinant antigen, such as is F. psychrophilum and/or infectious pancreatic necrosis virus (IPNV).
    Type: Grant
    Filed: April 17, 2017
    Date of Patent: May 19, 2020
    Assignee: BENCHMARK ANIMAL HEALTH LIMITED
    Inventors: Elizabeth Mary Crump, Jan Burian, Joseph Michale Bricker, William Wayne Kay, Norman William Johnson
  • Patent number: 10450544
    Abstract: Methods of producing, propagating and multiplying viruses, methods of identifying the presence of a virus in a sample, specifically methods using Japanese eel cell cultures. Also provided are an isolated Japanese eel cell culture, optionally infected with a virus, vaccines comprising viruses grown according to the methods of the invention, and a kit for propagating viruses comprising the Japanese eel cell culture. The virus may be a fish virus such as nodavirus, Infectious Pancreatic Necrosis Virus (IPNV) and Salmon Pancreas Disease Virus (SPDV).
    Type: Grant
    Filed: February 2, 2017
    Date of Patent: October 22, 2019
    Assignee: Benchmark Animal Health Limited
    Inventors: Lindsey Ann Toon, Ralf Hoffmann
  • Patent number: 9801908
    Abstract: The present disclosure relates to treatment of chitin-containing microorganism infection or colonization on an aquatic animal. The methods, systems, and kits provided herein facilitate termination and/or inhibition of proliferation of chitin-containing microorganisms (e.g., Saprolegnia and sea lice).
    Type: Grant
    Filed: December 17, 2014
    Date of Patent: October 31, 2017
    Assignee: BENCHMARK ANIMAL HEALTH LIMITED
    Inventors: Shimaa E. Ali, Even Thoen, Ida Skaar, Øystein Evensen